These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8098342)

  • 1. New approaches in the pharmacologic treatment of portal hypertension.
    Bosch J; García-Pagán JC; Feu F; Luca A; Fernández M; Pizcueta P; Rodés J
    J Hepatol; 1993; 17 Suppl 2():S41-5. PubMed ID: 8098342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
    Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of cirrhosis. I. Portal hypertension.
    Bosch J; García-Pagán JC
    J Hepatol; 2000; 32(1 Suppl):141-56. PubMed ID: 10728801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
    Bosch J
    P R Health Sci J; 2000 Mar; 19(1):57-67. PubMed ID: 10761206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta blockers in portal hypertension. Are they really a good option?
    López-Méndez E; Uribe M
    Ann Hepatol; 2006; 5(2):86-91. PubMed ID: 16807514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.
    Villanueva C; Graupera I; Aracil C; Alvarado E; Miñana J; Puente Á; Hernandez-Gea V; Ardevol A; Pavel O; Colomo A; Concepción M; Poca M; Torras X; Reñe JM; Guarner C
    Hepatology; 2017 May; 65(5):1693-1707. PubMed ID: 28100019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
    Escorsell A; Feu F; Bordas JM; García-Pagán JC; Luca A; Bosch J; Rodés J
    J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
    Castaño G; Viudez P; Sookoian S; Carlevaro O; Riccitelli M; Frider B
    Gastroenterol Hepatol; 2000; 23(6):275-81. PubMed ID: 15324622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effect of spironolactone in liver cirrhosis and propranolol-resistant portal hypertension.
    Sen S; De BK; Biswas PK; Biswas J; Das D; Maity AK
    Indian J Gastroenterol; 2002; 21(4):145-8. PubMed ID: 12385542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone.
    Merkel C; Sacerdoti D; Bolognesi M; Enzo E; Marin R; Bombonato G; Angeli P; Gatta A
    Hepatology; 1997 Jul; 26(1):34-9. PubMed ID: 9214449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
    Garcia-Pagán JC; Navasa M; Bosch J; Bru C; Pizcueta P; Rodés J
    Hepatology; 1990 Feb; 11(2):230-8. PubMed ID: 2307401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
    Aramaki T; Sekiyama T; Katsuta Y; Kurokawa H; Komeichi H; Tsutsui H; Terada H; Ohsuga M; Satomura K; Okumura H
    J Hepatol; 1992 May; 15(1-2):48-53. PubMed ID: 1354676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension.
    Albillos A; García-Pagán JC; Iborra J; Bandi JC; Cacho G; Pérez-Paramo M; Escorsell A; Calleja JL; Escartín P; Bosch J
    Gastroenterology; 1998 Jul; 115(1):116-23. PubMed ID: 9649466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
    Abraldes JG; Tarantino I; Turnes J; Garcia-Pagan JC; Rodés J; Bosch J
    Hepatology; 2003 Apr; 37(4):902-8. PubMed ID: 12668985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of variceal rebleeding.
    Bosch J; García-Pagán JC
    Lancet; 2003 Mar; 361(9361):952-4. PubMed ID: 12648985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review: pharmacotherapeutic agents in the treatment of portal hypertension.
    Lebrec D
    J Gastroenterol Hepatol; 1997 Feb; 12(2):159-66. PubMed ID: 9083918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on Doppler ultrasound parameters in patients with cirrhosis and portal hypertension.
    Orban Schiopu AM; Balas BI; Diculescu M
    Rom J Gastroenterol; 2005 Jun; 14(2):123-7. PubMed ID: 15990930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atorvastatin on portal hemodynamics and clinical outcomes in patients with cirrhosis with portal hypertension: a proof-of-concept study.
    Bishnu S; Ahammed SM; Sarkar A; Hembram J; Chatterjee S; Das K; Dhali GK; Chowdhury A; Das K
    Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):54-59. PubMed ID: 29099421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.